These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

944 related articles for article (PubMed ID: 17878391)

  • 21. In vitro stimulation and expansion of human tumour-reactive CD8+ cytotoxic T lymphocytes by anti-CD3/CD28/CD137 magnetic beads.
    Teschner D; Wenzel G; Distler E; Schnürer E; Theobald M; Neurauter AA; Schjetne K; Herr W
    Scand J Immunol; 2011 Aug; 74(2):155-64. PubMed ID: 21517928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 4-1BB regulates NKG2D costimulation in human cord blood CD8+ T cells.
    Kim YJ; Han MK; Broxmeyer HE
    Blood; 2008 Feb; 111(3):1378-86. PubMed ID: 18024793
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor-specific T cell activation by recombinant immunoreceptors: CD3 zeta signaling and CD28 costimulation are simultaneously required for efficient IL-2 secretion and can be integrated into one combined CD28/CD3 zeta signaling receptor molecule.
    Hombach A; Wieczarkowiecz A; Marquardt T; Heuser C; Usai L; Pohl C; Seliger B; Abken H
    J Immunol; 2001 Dec; 167(11):6123-31. PubMed ID: 11714771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Engineering artificial antigen-presenting cells to express a diverse array of co-stimulatory molecules.
    Suhoski MM; Golovina TN; Aqui NA; Tai VC; Varela-Rohena A; Milone MC; Carroll RG; Riley JL; June CH
    Mol Ther; 2007 May; 15(5):981-8. PubMed ID: 17375070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 4-1BBL costimulation retrieves CD28 expression in activated T cells.
    Habib-Agahi M; Jaberipour M; Searle PF
    Cell Immunol; 2009; 256(1-2):39-46. PubMed ID: 19217084
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cutting edge: predetermined avidity of human CD8 T cells expanded on calibrated MHC/anti-CD28-coated microspheres.
    Walter S; Herrgen L; Schoor O; Jung G; Wernet D; Bühring HJ; Rammensee HG; Stevanović S
    J Immunol; 2003 Nov; 171(10):4974-8. PubMed ID: 14607891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Generation of Pure Highly Functional Human Anti-Tumor Specific Cytotoxic T Lymphocytes With Stem Cell-Like Memory Features for Melanoma Immunotherapy.
    Hamieh M; Chatillon JF; Dupel E; Bayeux F; Fauquembergue E; Maby P; Drouet A; Duval-Modeste AB; Adriouch S; Boyer O; Latouche JB
    Front Immunol; 2021; 12():674276. PubMed ID: 34566953
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Preferential T cell expansion by artificial antigen presenting cells expressing 4-1BBL alone or in combination with CD80 or CD86.
    Habib-Agahi M; Jaberipour M; Phan TT; Searle PF
    Iran J Immunol; 2008 Sep; 5(3):136-47. PubMed ID: 18791280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different cytokine and stimulation conditions influence the expansion and immune phenotype of third-generation chimeric antigen receptor T cells specific for tumor antigen GD2.
    Gargett T; Brown MP
    Cytotherapy; 2015 Apr; 17(4):487-95. PubMed ID: 25573334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Engagement of NKG2D by cognate ligand or antibody alone is insufficient to mediate costimulation of human and mouse CD8+ T cells.
    Ehrlich LI; Ogasawara K; Hamerman JA; Takaki R; Zingoni A; Allison JP; Lanier LL
    J Immunol; 2005 Feb; 174(4):1922-31. PubMed ID: 15699119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Artificial antigen-presenting cells expressing CD80, CD70, and 4-1BB ligand efficiently expand functional T cells specific to tumor-associated antigens.
    Zeng W; Su M; Anderson KS; Sasada T
    Immunobiology; 2014 Aug; 219(8):583-92. PubMed ID: 24713579
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of melanoma antigen-specific cytotoxic T lymphocytes in vitro by stimulation with B7-expressing human melanoma cell lines.
    Fenton RG; Turcovski-Corrales SM; Taub DD
    J Immunother; 1998 Mar; 21(2):95-108. PubMed ID: 9551360
    [TBL] [Abstract][Full Text] [Related]  

  • 33. T cell retargeting with MHC class I-restricted antibodies: the CD28 costimulatory domain enhances antigen-specific cytotoxicity and cytokine production.
    Willemsen RA; Ronteltap C; Chames P; Debets R; Bolhuis RL
    J Immunol; 2005 Jun; 174(12):7853-8. PubMed ID: 15944290
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extensive replicative capacity of human central memory T cells.
    Maus MV; Kovacs B; Kwok WW; Nepom GT; Schlienger K; Riley JL; Allman D; Finkel TH; June CH
    J Immunol; 2004 Jun; 172(11):6675-83. PubMed ID: 15153483
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Murine CD8 lymphocyte expansion in vitro by artificial antigen-presenting cells expressing CD137L (4-1BBL) is superior to CD28, and CD137L expressed on neuroblastoma expands CD8 tumour-reactive effector cells in vivo.
    Yan X; Johnson BD; Orentas RJ
    Immunology; 2004 May; 112(1):105-16. PubMed ID: 15096190
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Costimulation of CD3/TcR complex with either integrin or nonintegrin ligands protects CD4+ allergen-specific T-cell clones from programmed cell death.
    Agea E; Bistoni O; Bini P; Migliorati G; Nicoletti I; Bassotti G; Riccardi C; Bertotto A; Spinozzi F
    Allergy; 1995 Aug; 50(8):677-82. PubMed ID: 7503404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 4-1BB-mediated expansion affords superior detection of in vivo primed effector memory CD8+ T cells from melanoma sentinel lymph nodes.
    Sluijter BJ; van den Hout MF; Stam AG; Lougheed SM; Suhoski MM; van den Eertwegh AJ; van den Tol MP; van Leeuwen PA; Meijer S; Scheper RJ; June CH; de Gruijl TD; Santegoets SJ
    Clin Immunol; 2010 Nov; 137(2):221-33. PubMed ID: 20708974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid expansion of cytomegalovirus-specific cytotoxic T lymphocytes by artificial antigen-presenting cells expressing a single HLA allele.
    Papanicolaou GA; Latouche JB; Tan C; Dupont J; Stiles J; Pamer EG; Sadelain M
    Blood; 2003 Oct; 102(7):2498-505. PubMed ID: 12805061
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential effects of B7-1 and B7-2 on the costimulation of mouse nonspecific cytotoxic T lymphocyte development in response to anti-CD3 antibody.
    Makrigiannis AP; Musgrave BL; Hoskin DW
    J Leukoc Biol; 1999 Nov; 66(5):792-802. PubMed ID: 10577511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ex vivo induction and expansion of antigen-specific cytotoxic T cells by HLA-Ig-coated artificial antigen-presenting cells.
    Oelke M; Maus MV; Didiano D; June CH; Mackensen A; Schneck JP
    Nat Med; 2003 May; 9(5):619-24. PubMed ID: 12704385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 48.